Literature DB >> 16512986

A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancer.

Jeffrey A Bogart1, Ramaswamy Govindan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16512986     DOI： 10.3816/CLC.2006.n.009

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  3 in total

1.  Groove-type recognition of chlamydiaceae-specific lipopolysaccharide antigen by a family of antibodies possessing an unusual variable heavy chain N-linked glycan.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Radka Saldova; Mohankumar Muniyappa; Lore Brade; Pauline M Rudd; David J Harvey; Paul Kosma; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2014-03-28       Impact factor: 5.157

2.  Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer.

Authors:  Tim J Kruser; Eric A Armstrong; Amol J Ghia; Shyhmin Huang; Deric L Wheeler; Robert Radinsky; Daniel J Freeman; Paul M Harari
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

3.  Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma.

Authors:  Olivier Bailon; Kader Chouahnia; Alexandre Augier; Thierry Bouillet; Ségolène Billot; Irène Coman; Rénata Ursu; Catherine Belin; Laurent Zelek; Gaëtan Des Guetz; Christine Levy; Antoine F Carpentier; Jean-François Morere
Journal:  Neuro Oncol       Date:  2012-02-22       Impact factor: 12.300
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.